{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:10:41Z","timestamp":1783933841889,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>\n                    Proton pump inhibitors (PPIs) are widely prescribed for acid-related disorders, but emerging evidence suggests they may influence glucose metabolism. This meta-analysis evaluates the effect of PPIs on glycemic control in patients with and without type 2 diabetes mellitus (T2DM). We systematically searched PubMed, Cochrane Library, Embase, and Scopus for randomized controlled trials and observational studies reporting fasting blood glucose (FBG), HbA1c, or insulin resistance with PPI use. Risk of bias was assessed using the Cochrane RoB 2.0 tool for randomized trials and the Newcastle\u2013Ottawa Scale for observational studies. Data were synthesized using a random-effects model and expressed as mean differences with 95% confidence intervals (CIs). The review was not prospectively registered in PROSPERO or any other database. Fifteen studies involving 2,038 participants were included in the study. PPI use significantly reduced FBG (mean decrease: 5.32 mg\/dL; 95% CI: 2.01\u20138.63;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.002; 9 studies,\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    = 1243). HbA1c reductions were observed in some studies (7 studies,\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    = 1121), but findings were inconsistent. No significant effect was seen on insulin resistance (4 studies,\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    = 412). Subgroup analyses suggested greater benefits in patients with poorly controlled T2DM. Reported adverse events were mild, including gastrointestinal symptoms and headache. Small sample sizes, study heterogeneity, and moderate risk of bias in some trials limited the certainty of evidence. PPIs may provide modest improvements in glycemic control, particularly among patients with poorly controlled T2DM. While generally safe in the short term, the long-term benefits and risks remain unclear. Regular glucose monitoring may be advisable in diabetic patients on chronic PPI therapy.\n                  <\/jats:p>","DOI":"10.4103\/jmh.jmh_210_25","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:00:16Z","timestamp":1783497616000},"page":"208-216","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Proton Pump Inhibitors on Blood Glucose in Type 2 Diabetes: A Systematic Review with Meta-analysis"],"prefix":"10.4103","volume":"17","author":[{"given":"Prabhat Kumar","family":"Agrawal","sequence":"first","affiliation":[{"name":"Department of Medicine, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Varshney","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Noida International Institute of Medical Sciences, Gautam Budh Nagar, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Dev","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Agastya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipta Kumar","family":"Panda","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Surgery, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"R1-20260713","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"R2-20260713","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.2337\/dc24-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: Standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"R3-20260713","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.gastro.2013.01.004","article-title":"The intestinal glucose-apelin cycle controls carbohydrate absorption in mice","volume":"144","author":"Dray","year":"2013","journal-title":"Gastroenterology"},{"key":"R4-20260713","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/gutjnl-2020-322557","article-title":"Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies","volume":"70","author":"Yuan","year":"2021","journal-title":"Gut"},{"key":"R5-20260713","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcjd.2013.10.008","article-title":"The effect of proton pump inhibitors on glycated hemoglobin levels in patients with type 2 diabetes mellitus","volume":"39","author":"Han","year":"2015","journal-title":"Can J Diabetes"},{"key":"R6-20260713","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1210\/clinem\/dgab353","article-title":"Effects of proton pump inhibitors on glycemic control and incident diabetes: A systematic review and meta-analysis","volume":"106","author":"Peng","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20260713","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R8-20260713","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mehy.2009.02.010","article-title":"Proton pump inhibitors as a treatment method for type II diabetes","volume":"73","author":"Mefford","year":"2009","journal-title":"Med Hypotheses"},{"key":"R9-20260713","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4239\/wjd.v2.i12.217","article-title":"Are proton pump inhibitors a new antidiabetic drug? A cross sectional study","volume":"2","author":"Boj-Carceller","year":"2011","journal-title":"World J Diabetes"},{"key":"R10-20260713","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00592-015-0721-4","article-title":"Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control","volume":"52","author":"Barchetta","year":"2015","journal-title":"Acta Diabetol"},{"key":"R11-20260713","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/j.diabres.2010.09.007","article-title":"Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients \u2013 a retrospective analysis","volume":"90","author":"Hove","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"R12-20260713","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3122\/jabfm.2012.01.100161","article-title":"Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes","volume":"25","author":"Crouch","year":"2012","journal-title":"J Am Board Fam Med"},{"key":"R13-20260713","doi-asserted-by":"crossref","first-page":"E2105","DOI":"10.1210\/jc.2012-1720","article-title":"Pantoprazole improves glycemic control in type 2 diabetes: A randomized, double-blind, placebo-controlled trial","volume":"97","author":"Singh","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20260713","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.diabres.2015.01.039","article-title":"Effect of pantoprazole on insulin secretion in drug-na\u00efve patients with type 2 diabetes","volume":"108","author":"Gonz\u00e1lez-Ortiz","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"R15-20260713","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00125-012-2714-y","article-title":"Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: A randomised double-blind prospective placebo-controlled study","volume":"56","author":"Hove","year":"2013","journal-title":"Diabetologia"},{"key":"R16-20260713","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1507\/endocrj.EJ14-0208","article-title":"Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes","volume":"61","author":"Takebayashi","year":"2014","journal-title":"Endocr J"},{"key":"R17-20260713","first-page":"218","article-title":"The effect of proton pump inhibitors on glycaemic control in diabetic patients","volume":"15","author":"Rajput","year":"2020","journal-title":"J Taibah Univ Med Sci"},{"key":"R18-20260713","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13098-023-01051-8","article-title":"Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: A pharmacoepidemiological cohort study","volume":"15","author":"Lin","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"R19-20260713","first-page":"1","article-title":"Study of the effect of pantoprazole on glycemic control of type-2 diabetes mellitus in tertiary care center and hospital in North India","volume":"20","author":"Agrawal","year":"2018","journal-title":"J Med Trop"},{"key":"R20-20260713","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40618-013-0040-y","article-title":"Pantoprazole may improve beta cell function and diabetes mellitus","volume":"37","author":"Inci","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"R21-20260713","first-page":"e020621189270","article-title":"Possible mechanisms of proton pump inhibitors on glycemic control in type 2 diabetes mellitus: A brief review","volume":"17","author":"Vafaeimanesh","year":"2021","journal-title":"Curr Diabetes Rev"}],"container-title":["Journal of Mid-life Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/jmh.jmh_210_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:00:13Z","timestamp":1783933213000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/jmh.jmh_210_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jmh.jmh_210_25","relation":{},"ISSN":["0976-7800","0976-7819"],"issn-type":[{"value":"0976-7800","type":"print"},{"value":"0976-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-08-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}